Biora Therapeutics Inc
NASDAQ:BIOR

Watchlist Manager
Biora Therapeutics Inc Logo
Biora Therapeutics Inc
NASDAQ:BIOR
Watchlist
Price: 0.22 USD
Market Cap: 994.4k USD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Biora Therapeutics Inc

Revenue
892k USD
Operating Expenses
-61.8m USD
Operating Income
-60.9m USD
Other Expenses
29.3m USD
Net Income
-31.5m USD

Margins Comparison
Biora Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Biora Therapeutics Inc
NASDAQ:BIOR
994.4k USD
-6 824%
-3 536%
US
CVS Health Corp
NYSE:CVS
98.9B USD
3%
0%
US
Cigna Group
XMUN:CGN
62.3B EUR
4%
2%
US
Cigna Corp
NYSE:CI
73B USD
4%
2%
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR
10%
5%
DE
Fresenius Medical Care AG
XMUN:FME
23.6B EUR
7%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
21.2B USD
10%
6%
US
Quest Diagnostics Inc
NYSE:DGX
19.9B USD
15%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR
7%
4%
US
Guardant Health Inc
NASDAQ:GH
12.2B USD
-48%
-44%
US
DaVita Inc
NYSE:DVA
8.4B USD
15%
6%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Biora Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Biora Therapeutics Inc
NASDAQ:BIOR
994.4k USD
28%
-128%
86%
-537%
US
CVS Health Corp
NYSE:CVS
98.9B USD
1%
0%
7%
1%
US
Cigna Group
XMUN:CGN
62.3B EUR
15%
4%
10%
6%
US
Cigna Corp
NYSE:CI
73B USD
15%
4%
10%
6%
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR
6%
3%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
23.6B EUR
5%
2%
5%
4%
US
Laboratory Corporation of America Holdings
NYSE:LH
21.2B USD
10%
5%
9%
6%
US
Quest Diagnostics Inc
NYSE:DGX
19.9B USD
14%
6%
11%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR
5%
2%
5%
4%
US
Guardant Health Inc
NASDAQ:GH
12.2B USD
192%
-28%
-36%
-67%
US
DaVita Inc
NYSE:DVA
8.4B USD
-834%
4%
13%
10%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less